Extract from the Register of European Patents

EP About this file: EP2240127

EP2240127 - APPARATUS FOR TREATING OBESITY AND REFLUX DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.02.2023
Database last updated on 28.03.2026
FormerThe patent has been granted
Status updated on  04.03.2022
FormerGrant of patent is intended
Status updated on  08.11.2021
FormerExamination is in progress
Status updated on  22.10.2021
Most recent event   Tooltip10.02.2023No opposition filed within time limitpublished on 15.03.2023  [2023/11]
Applicant(s)For all designated states
Implantica Patent Ltd.
Ideon Science Park
223 70 Lund / SE
[2019/25]
Former [2014/07]For all designated states
Kirk Promotion LTD.
Frejgatan 13, Att. 1492
114 79 Stockholm / SE
Former [2013/09]For all designated states
Milux Holding SA
6 rue Guillaume Schneider
2522 Luxembourg / LU
Former [2010/42]For all designated states
Milux Holding SA
12 Rue Guillaume Schneider
2522 Luxembourg / LU
Inventor(s)01 / FORSELL, Peter
Aegeristrasse 66
6300 Zug / CH
 [2022/14]
Former [2010/42]01 / FORSELL, Peter
Aegeristrasse 66
CH-6300 Zug / CH
Representative(s)(deleted)
[2013/09]
Former [2010/42]Aurell, Henrik
Albihns.Zacco Studentgatan 4 Box 4289
203 14 Malmö / SE
Application number, filing date09705034.829.01.2009
[2010/42]
WO2009SE00053
Priority number, dateUS20080006719P29.01.2008         Original published format: US 6719 P
SE2008000213810.10.2008         Original published format: SE 0802138
[2010/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009096868
Date:06.08.2009
Language:EN
[2009/32]
Type: A1 Application with search report 
No.:EP2240127
Date:20.10.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 06.08.2009 takes the place of the publication of the European patent application.
[2010/42]
Type: B1 Patent specification 
No.:EP2240127
Date:06.04.2022
Language:EN
[2022/14]
Type: B8 Corrected title page of specification 
No.:EP2240127
Date:18.05.2022
[2022/20]
Search report(s)International search report - published on:SE06.08.2009
(Supplementary) European search report - dispatched on:EP01.10.2012
ClassificationIPC:A61F5/00, A61N1/36, // A61F2/04, A61B17/00, A61B17/04, A61B17/068, A61B17/30
[2021/47]
CPC:
A61F5/003 (EP,SE,US); A61F2/04 (EP,SE,US); A61F5/0036 (EP,CN,SE,US);
A61F5/0083 (EP,US); A61B1/04 (EP,US); A61B1/06 (EP,US);
A61B1/2736 (EP,US); A61B1/3132 (EP,US); A61B1/32 (EP);
A61B17/00234 (EP,US); A61B17/0469 (EP,US); A61B17/068 (EP,US);
A61F5/0003 (EP,US); A61F5/0013 (EP,US); A61F5/0026 (EP,US);
A61F5/0033 (EP,US); A61F5/004 (EP,US); A61F5/0043 (EP,US);
A61F5/0046 (EP,US); A61F5/005 (EP,US); A61F5/0063 (EP,CN,US);
A61F5/0069 (EP,SE,US); A61F5/0073 (EP,US); A61F5/0079 (EP,US);
A61F5/0086 (EP,US); A61F5/0089 (EP,US); A61N1/36007 (EP,US);
A61B17/00 (US); A61B17/064 (US); A61B17/0682 (EP,US);
A61B17/08 (US); A61B17/30 (US); A61B17/320016 (US);
A61B17/3423 (US); A61B17/3474 (US); A61B17/3478 (EP);
A61B2017/00278 (EP,US); A61B2017/00561 (EP,US); A61B2017/00818 (EP,US);
A61B2017/00827 (EP,US); A61B2017/081 (US); A61B2017/306 (EP,US);
A61B2017/308 (EP,US); A61F2002/044 (EP,US); A61F2002/045 (US);
A61F2005/0016 (EP,US); A61F2005/002 (EP,US); A61F2005/0023 (EP,US);
A61F2250/0001 (EP,US); A61F2250/0004 (EP,US); A61F5/0076 (EP,US) (-)
Former IPC [2012/44]A61F5/00
Former IPC [2010/42]A61F5/00, A61F2/04
Designated contracting statesCH,   DE,   FR,   GB,   LI [2022/19]
Former [2022/14]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Former [2010/42]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VORRICHTUNG ZUR BEHANDLUNG VON FETTLEIBIGKEIT UND REFLUXKRANKHEIT[2010/42]
English:APPARATUS FOR TREATING OBESITY AND REFLUX DISEASE[2010/42]
French:APPAREIL, SYSTÈME ET MÉTHODE DE TRAITEMENT DE L'OBÉSITÉ ET DU REFLUX GASTRO-OESOPHAGIEN[2010/42]
Entry into regional phase25.08.2010National basic fee paid 
25.08.2010Search fee paid 
25.08.2010Designation fee(s) paid 
25.08.2010Examination fee paid 
Examination procedure25.08.2010Examination requested  [2010/42]
29.04.2013Amendment by applicant (claims and/or description)
14.07.2015Despatch of a communication from the examining division (Time limit: M04)
23.11.2015Reply to a communication from the examining division
04.10.2021Cancellation of oral proceeding that was planned for 07.10.2021
07.10.2021Date of oral proceedings (cancelled)
14.10.2021Despatch of a communication from the examining division (Time limit: M04)
15.10.2021Reply to a communication from the examining division
09.11.2021Communication of intention to grant the patent
01.03.2022Fee for grant paid
01.03.2022Fee for publishing/printing paid
01.03.2022Receipt of the translation of the claim(s)
Divisional application(s)EP22166503.7  / EP4091584
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.07.2015
Opposition(s)10.01.2023No opposition filed within time limit [2023/11]
Fees paidRenewal fee
27.01.2011Renewal fee patent year 03
31.01.2012Renewal fee patent year 04
25.07.2013Renewal fee patent year 05
28.01.2014Renewal fee patent year 06
26.01.2015Renewal fee patent year 07
01.02.2016Renewal fee patent year 08
31.01.2017Renewal fee patent year 09
31.01.2018Renewal fee patent year 10
31.01.2019Renewal fee patent year 11
31.01.2020Renewal fee patent year 12
01.02.2021Renewal fee patent year 13
31.01.2022Renewal fee patent year 14
Penalty fee
Additional fee for renewal fee
31.01.201305   M06   Fee paid on   25.07.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y] WO2005105003  (SYNECOR LLC et al.) [Y] 1-6,10,11,13,16,17 * page 3 - page 8 * * page 9, line 9 - line 22 *
 [Y] EP1743604  (ETHICON ENDO SURGERY INC et al.) [Y] 1-6,10,11,13,16,17 * the whole document *
 [Y] WO2004112563  (IMPULSE DYNAMICS NV et al.) [Y] 11 * the whole document *
 [Y] WO2006044640  (BFKW LLC et al.) [Y] 11 * the whole document *
 [A] US2004111116  (KENNEDY JOHN et al.) [A] 6 * the whole document *
 [A] EP1736123  (ETHICON ENDO SURGERY INC et al.) [A] 1-18 * the whole document *
 [A] US2004044354  (GANNOE JAMES et al.) [A] 1-18 * the whole document *
 [A] WO0000108  (KIRK PROMOTIONS LIMITED et al.) [A] 1-18 * the whole document *
International search[A] US2005261712  (BALBIERZ DANIEL J et al.) [A]
 [A] WO2005105003  (SYNECOR LLC et al.) [A]
 [A] WO0167964  (MEDIGUS LTD et al.) [A]
 [A] US2003055442  (LAUFER MICHAEL D et al.) [A]
 [A] US2003163029  (SONNENSCHEIN ELAZAR et al.) [A]
 [A] US2005245957  (STARKEBAUM WARREN L et al.) [A]
 [A] US5297536  (WILK PETER J et al.) [A]
 [A] WO0158391  (OBTECH MEDICAL AG et al.) [A]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.